Literature DB >> 14726223

Inhibitory effect of polypeptide from Chlamys farreri on ultraviolet A-induced oxidative damage on human skin fibroblasts in vitro.

Yan-Tao Han1, Zhi-Wu Han, Guo-Ying Yu, Yue-Jun Wang, Rui-Yao Cui, Chun-Bo Wang.   

Abstract

We have previously reported that polypeptide from Chlamys farreri (PCF) inhibits the oxidative damage of ultraviolet A (UVA) on HeLa cells in vitro [Acta Pharm. Sin. 23 (2002) 961]. To further elucidate a possible role for PCF on UVA-damaged normal human cells, we established the oxidative damage models of normal human dermal fibroblasts (NHDF) exposed to UVA to study the protective effect of PCF on human dermal fibroblasts in vitro. In this study, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method was used to detect the cell viability. The intracellular superoxide dismutase (SOD), glutathione peroxidase (GSH-px), catalase (CAT), xanthine oxidase (XOD), malondialdehyde (MDA), reactive oxygen species (ROS), total antioxidative capacity (T-AOC), and anti-superoxide anion capacity (A-ASC) were measured. The effect of PCF on UVA-induced apoptosis were investigated by Annexin V-FITC assay. Intracellular calcium was determined with the calcium-sensitive fluorochrome Fluo-3, and mitochondrial transmembrane potential with rhodamine 123. Comet assay was employed to detect the UVA-induced DNA damage. The ultrastructure of cell was observed under transmission electron microscope. The results indicated that PCF could greatly enhance the viability of NHDF and markedly promote SOD, GSH-px, T-AOC, and A-ASC, while the amounts of MDA and ROS, the activity of XOD were decreased. PCF could inhibit UVA-induced apoptosis and DNA damage in NHDF. The concentration of cellular free calcium was decreased and the mitochondrial transmembrane potential was increased by PCF. In ultrastructure of NHDF, PCF could greatly decrease UVA-induced damage, especially membrane. Our results suggest that the supplementation of PCF appears to reduce the UVA-induced normal human dermal fibroblasts damage efficiently. It may be involved in the PCF's abilities of scavenging oxygen free radical, inhibiting lipid peroxidation, increasing antioxidative enzymes, decreasing intracellular calcium and protection of membrane structure in NHDF irradiated by UVA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726223     DOI: 10.1016/j.phrs.2003.09.009

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Inhibition of UVA-induced apoptotic signaling pathway by polypeptide from Chlamys farreri in human HaCaT keratinocytes.

Authors:  Jin-Lian Li; Ning Liu; Xue-Hong Chen; Mi Sun; Chun-Bo Wang
Journal:  Radiat Environ Biophys       Date:  2007-05-09       Impact factor: 1.925

2.  In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action.

Authors:  Sheng Xiong; Hui-dan Pang; Jun Fan; Feng Ge; Xiao-xia Yang; Qiu-ying Liu; Xiao-jian Liao; Shi-hai Xu
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

Review 3.  Marine Fish Proteins and Peptides for Cosmeceuticals: A Review.

Authors:  Jayachandran Venkatesan; Sukumaran Anil; Se-Kwon Kim; Min Suk Shim
Journal:  Mar Drugs       Date:  2017-05-18       Impact factor: 5.118

4.  Effects of icariside II on brain tissue oxidative stress and Nrf2/HO-1 expression in rats with cerebral ischemia-reperfusion injury1.

Authors:  Yan Li; Fanjun Meng
Journal:  Acta Cir Bras       Date:  2019-02-28       Impact factor: 1.388

Review 5.  Application of enzymes in the preparation of wheat germ polypeptides and their biological activities.

Authors:  Ke Du; Shuangqi Tian; Hu Chen; Sensen Gao; Xianyou Dong; Feng Yan
Journal:  Front Nutr       Date:  2022-07-18

6.  Effects of collagen and collagen hydrolysate from jellyfish umbrella on histological and immunity changes of mice photoaging.

Authors:  Jian Fan; Yongliang Zhuang; Bafang Li
Journal:  Nutrients       Date:  2013-01-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.